TD Cowen Reiterates Buy Rating on Sana Biotechnology (SANA) Mar 6, 2026 12:35PM
Sana Biotechnology to Present at March 2026 Investor Conferences Feb 23, 2026 04:05PM
Sana Biotechnology to Present at the TD Cowen Immunology & Inflammation Summit Nov 4, 2025 04:05PM
Sana Biotechnology to Present at the TD Cowen Immunology & Inflammation Summit Nov 4, 2025 04:05PM
Sana Biotechnology Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares Aug 20, 2025 04:05PM


Aug 6, 2025 11:24PM Sana Biotechnology prices $75 million public offering at $3.35 per share
Aug 6, 2025 11:24PM Sana Biotechnology Announces Pricing of Public Offering
Aug 6, 2025 04:38PM Sana Biotechnology launches $75 million public stock offering
Aug 6, 2025 04:38PM Sana Biotechnology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
Feb 24, 2025 04:05PM Sana Biotechnology to Present at the Cowen 45th Annual Health Care Conference
Jan 8, 2025 05:31AM TD Cowen Upgrades Sana Biotechnology (SANA) to Buy
Feb 28, 2024 04:05PM Sana Biotechnology to Present at the Cowen 44th Annual Health Care Conference
Aug 14, 2023 05:56AM TD Cowen Starts Sana Biotechnology (SANA) at Market Perform, 'on the sideline pending early persistence data'
Mar 1, 2023 04:05PM Sana Biotechnology to Present at the Cowen 43rd Annual Health Care Conference
Mar 1, 2023 04:05PM Sana Biotechnology to Present at the Cowen 43rd Annual Health Care Conference